Akero Therapeutics, Inc. (AKRO) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Cash from Operations | -67.17M | -48.25M | -67.66M | -67.09M | -70.42M | -57.45M | -35.14M | -48.63M | -49.72M | -22.39M | -24.63M | -25.51M | -24.62M | -19.51M | -22.88M | -26.7M | -14.61M | -20.03M | -18.35M | -23.39M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 4.62% | 16.03% | -92.56% | -37.97% | -41.64% | -156.61% | -42.66% | -90.63% | -101.91% | -14.76% | -7.68% | 4.45% | -68.59% | 2.62% | -24.69% | -14.11% | -8.13% | 11.29% | -62.11% | -100.83% |
| Net Income | -81.57M | -70.5M | -70.72M | -70.02M | -72.7M | -55.99M | -53.34M | -55.19M | -39.66M | -31.08M | -25.83M | -23.06M | -35.54M | -27.4M | -26.03M | -32.42M | -24.33M | -28.93M | -15.09M | -29.71M |
| Depreciation & Amortization | 179K | -2.67M | -2.29M | 15K | -10.11M | 1K | 1K | 2K | 5K | 11K | 68K | 65K | 11K | 65K | 64K | 63K | 60K | 60K | 61K | 60K |
| Stock-Based Compensation | 9.26M | 9.05M | 8.78M | 7.18M | 7.47M | 7.66M | 7.4M | 6.12M | 5.74M | 4.8M | 0 | 0 | 11.73M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.71M | -3.27M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 5.95M | 198K | 168K | -2.87M | 11.11M | -2.24M | -2.27M | -8.2M | 175K | -1.27M | 4.17M | 4.2M | 191K | 4.21M | 3.44M | 3.12M | 2.9M | 2.62M | 2.48M | 2.04M |
| Working Capital Changes | -992K | 15.68M | -3.61M | -1.39M | -6.19M | -6.88M | 13.07M | 3.93M | -12.71M | 5.16M | -3.04M | -6.72M | -1.01M | 3.62M | -348K | 2.54M | 6.76M | 6.22M | -5.8M | 4.22M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 0 | 2.39M | 1.81M | -16.11M | 10.57M | 1.09M | 6.46M | -4.23M | 1.34M | 2.88M | -631K | 1.68M | -853K | 2.39M | -2.25M | -196K | 4.59M | -2.3M | 1.18M | -1.21M |
| Cash from Investing | 56.78M | 79.34M | -482.18M | 15.27M | 73.07M | -255.9M | 57.85M | 12.79M | -125.7M | -128.3M | 17.59M | -101.44M | 3M | 11.87M | 22.75M | 12M | 21.93M | -10.65M | 19M | 17.9M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 56.78M | 0 | 0 | 0 | 0 | -999K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -34.03M | 3.43M | 395.53M | 75.99M | 3.07M | -150K | 366.94M | 502K | 806K | 336.86M | 15.15M | 2.72M | 217.9M | 34.88M | 132K | 243K | 69K | 266K | 24K | 59K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 10M | 0 | 0 | 0 | 14.97M | -338K | 0 | 9.74M | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 1000K | 1000K | 1000K | 1000K | -150K | 1000K | 502K | 806K | 1000K | 178K | 1000K | 1000K | 1000K | 132K | 243K | 69K | 266K | 24K | 59K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -336.86M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -34.03M | 0 | 0 | 8.35M | 0 | 0 | 1.5M | 336.86M | 0 | 1.43M | 0 | 0 | 1.7M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | -44.42M | 34.53M | -154.32M | 24.17M | 5.71M | -313.5M | 389.65M | -35.34M | -174.61M | 186.16M | 8.11M | -124.23M | 196.28M | 27.24M | 6K | -14.45M | 7.4M | -30.42M | 718K | -5.44M |
| Free Cash Flow | -67.17M | -48.25M | -67.66M | -67.09M | -70.42M | -58.45M | -35.14M | -48.63M | -49.72M | -22.39M | -24.63M | -25.51M | -24.62M | -19.51M | -22.88M | -26.7M | -14.61M | -20.03M | -18.35M | -23.4M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 4.62% | 17.46% | -92.56% | -37.97% | -41.64% | -161.07% | -42.66% | -90.63% | -101.91% | -14.76% | -7.68% | 4.45% | -68.59% | 2.62% | -24.69% | -14.08% | -7% | 11.29% | -62.11% | -100.88% |
| FCF per Share | -0.82 | -0.59 | -0.86 | -0.95 | -1.01 | -0.85 | -0.59 | -0.87 | -0.89 | -0.43 | -0.52 | -0.55 | -0.64 | -0.55 | -0.65 | -0.77 | -0.42 | -0.58 | -0.53 | -0.67 |
| FCF Conversion (FCF/Net Income) | 0.82x | 0.68x | 0.96x | 0.96x | 0.97x | 1.03x | 0.66x | 0.88x | 1.25x | 0.72x | 0.95x | 1.11x | 0.69x | 0.71x | 0.88x | 0.82x | 0.60x | 0.69x | 1.22x | 0.79x |
| Interest Paid | 1.24M | 0 | 0 | 1.03M | 0 | 0 | 0 | 0 | 0 | 670K | 0 | 0 | 189K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |